- Takeda to buy Millennium for $8.2bn in cash
- Millennium in giant cancer deal with Ortho Biotech
- J&J gets US co-promotion rights to Millennium's Velcade
- Takeda gets Japanese rights to 13 Amgen compounds
- Takeda to sell GVAX immunotherapy for Cell Genesys; ends
- Takeda acquires Syrrx
- Millennium to buy AnorMed; outbid
- Genzyme completes acquisition of AnorMed
- Millennium acquires Cor Therapeutics for $1.8bn
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. firstname.lastname@example.org.
All fields are required.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.